The Biomedical Ultrasonics, Biotherapy and Biopharmaceuticals Laboratory (BUBBL) at the University of Oxford has been developing novel ultrasound-based therapies for non-invasive surgery and drug delivery since its creation in 2004, and has been working closely with Sonic Concepts across all stages of technological development, from early laboratory concept studies to in vivo experimentation and clinical trials. Throughout this fruitful collaboration, we have come to expect not only excellence in manufacturing, acoustic performance and servicing of transducers, but also creative and expert input into the design, modelling and implementation of innovative and demanding ultrasound transducers for a broad range of applications. A key feature of this interaction has been the excellent agreement consistently obtained between acoustic modelling during the design phase and the resulting acoustic field, which has enabled us to push the boundaries of customization with confidence.
Professor Constantin Coussios
Statutory Chair of Biomedical Engineering, University of Oxford
Director, Oxford Centre for Drug Delivery Devices
Sonic Concepts understands how to optimize transducer performance to the harsh marine environment we operate in. As a critical supplier, they continue to provide high-quality transducer arrays to our sonar systems.
Joe Burch, President
George Keilman is arguably one of the most successful entrepreneurs in focused ultrasound.
FOCUSED ULTRASOUND FOUNDATION